EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    The 2025 Agenda: Navigating New European Compliance Challenges in Pharma

    EU pharma industry expectate new regulations changes in the year European Medicines Agency EMA and other regulatory authorities in the continent gradually increase regulatory requirements that exercise greater pressure on business entities to implement patientoriented sustainable and innovative production standards

    How Pharma Companies Can Strengthen Their GMP Compliance Strategies

    For most of the past two decades Good Manufacturing Practice in Europe was treated as a specialist discipline Quality heads owned it site directors funded it and the executive committee heard about it mainly when an inspection went wrong That arrangement is no longer workable The cost of a single serious GMP failure today extends well beyond a remediation budget it can freeze a product launch trig...

    The Growing Role of Advanced Therapies in European Drug Development

    For most of the past two decades European pharmaceutical strategy was built around molecules that could be manufactured at scale shipped in bulk and dosed repeatedly Advanced therapies break almost every one of those assumptions A gene therapy may be given once A cell therapy may be manufactured for a single patient from that patients own cells A tissueengineered product may sit closer to surgery...

    Business Transformation Strategies for the Pharmaceutical Industry

    The pharmaceutical industry is at a crossroads Drug development timelines remain long regulatory scrutiny keeps intensifying and patients now expect the same seamless digital experiences they get from banking apps or online retailers Against this backdrop pharma business transformation has moved from a nicetohave to a survival requirement

    Sustainability in Pharma Manufacturing: A Focus on Green Practices

    The pharmaceutical industry is pivotal to global healthcare but its manufacturing processes typically carry a significant environmental burden In recent years there has been an increasing recognition of the importance of sustainability in pharmaceutical manufacturing

    The New CDMO Strategy: Capacity Expansion for Advanced Therapies

    Advanced therapies have moved from scientific curiosity to commercial obligation and the pharmaceutical outsourcing sector is rebuilding itself around that shift This article examines why capacity expansion strategy is migrating from cleanroom square metres towards modularity

TOP ARTICLES

press releases Read more...

NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury

NervGen NASDAQ NGEN a latestage clinical biopharmaceutical company developing firstinclass neuroreparative therapeutics for spinal cord injury SCI and other neurotraumatic and neurologic conditions today announced

Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for the Treatment of Huntington’s Disease

Lineage Cell Therapeutics Inc NYSE American and TASE LCTX a clinicalstage biotechnology company developing allogeneic off the shelf cell therapies for serious medical conditions today announced that the Company has acquired NeuroAirmid

Instem and Sable Bio Launch Partnership to Accelerate Target Risk Assessment Through AI-Powered Scientific Intelligence

Instem a leading provider of software solutions and scientific services for drug discovery and development today announced a strategic partnership with Sable Bio to transform how biopharmaceutical organizations evaluate target safety and risk

Laboratoires Pierre Fabre and XtalPi Announce an AI-Driven Collaboration Focused on Drug Discovery

Laboratoires Pierre Fabre and XtalPi are pleased to announce an agreement under which they will collaborate on the discovery of novel clinical candidates across a number of research programs in the field of oncology potentially dermatology and rare diseases

24 - 27

Nov 2026

Pharmtech & Ingredients 2026

Crocus Expo, Pavilion 2, Mosco...

24 - 25

Nov 2026

BioPharma Deals Conference 2026

Science Congress Center, Munic...

25 - 25

Nov 2026

What’s Next for Pharma Marketing in 2027

Landesmuseum Zürich, Zurich, S...

26 - 28

Nov 2026

One Health Conference 2026

Thapar Institute of Engineerin...

01 - 03

Dec 2026

Pharmaceutical Launch Excellence Summit

Novotel Amsterdam City, Nether...

01 - 03

Dec 2026

10th Antifibrotic Drug Development

Boston, MA at the Hotel Common...

02 - 04

Dec 2026

Genome Informatics 2026

Wellcome Genome Campus, UK

LATEST NEWS Read more...

Immuneering and Astellas to Evaluate Combination Treatments for CLDN18.2-Expressing Pancreatic Cancer

Immuneering Corporation Nasdaq IMRX has entered into a clinical trial collaboration and supply agreement with Astellas Pharma Global Development Inc a subsidiary of Astellas Pharma Inc TSE to evaluate combination treatments for patients with pancreatic cancer whose tumours express CLDN

Takeda Launches ORZEYFUL (Oveporexton), the First Orexin Agonist for Narcolepsy Type 1, in the US

Takeda TSE NYSE TAK has announced the US launch of ORZEYFUL oveporexton CIV now available by prescription for adults with narcolepsy type NT also known as narcolepsy with cataplexy The medicine is the first and only orexin agonist available for this condition

Applied Biologics Partners with Dartmouth College on Computational Protein Engineering Research

Applied Biologics a biopharmaceutical company developing biologic and gene therapies for serious diseases has entered into a research collaboration agreement with Dartmouth Colleges Thayer School of Engineering

Onco-Innovations Agrees to Terminate Performance-Based Funding Arrangement with Sorbie

OncoInnovations Limited Cboe ONCO has entered into an agreement with Sorbie Bornholm LP SBLP and Sorbie Investments LLP SILP to terminate its previously announced performancebased funding arrangement which was disclosed on July

Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission

Oncovita a French biotechnology company specialized in therapeutic and prophylactic vaccines today announced that the European Commission has granted orphan medicinal product designation to its lead investigational candidate MVdeltaC for the treatment of mesothelioma

DeepLife and 3billion partner to discover small-molecule therapeutics against genetic modifier targets across multiple diseases

DeepLife a Parisbased techbio company developing AIpowered digital twins of human cells and billion an AIpowered genomics company specializing in rare disease diagnostics and drug discovery today announced a codevelopment collaboration to discover and develop new smallmolecule therapeutics